Synergistic Effects of the RAR alpha Agonist Tamibarotene and the Menin Inhibitor Revumenib in Acute Myeloid Leukemia Cells with KMT2A Rearrangement or NPM1 Mutation.

Autor: Fleischmann, Maximilian1 (AUTHOR) maximilian.fleischmann@med.uni-jena.de, Bechwar, Julia1 (AUTHOR), Voigtländer, Diana1 (AUTHOR), Fischer, Mike1 (AUTHOR), Schnetzke, Ulf1 (AUTHOR), Hochhaus, Andreas1 (AUTHOR), Scholl, Sebastian1 (AUTHOR) sebastian.scholl@med.uni-jena.de
Zdroj: Cancers. Apr2024, Vol. 16 Issue 7, p1311. 16p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje